$3M has been awarded by the NIH for the development of pediatric medicine using 3D printing.

Share this story

Transforming Pediatric Medication with 3D Printing

Medication administration to pediatric patients has always presented unique challenges due to their constantly changing needs and individualization of treatment. Traditional manufacturing methods often fail to meet the specific requirements of children, resulting in difficulties in swallowing, improper dosage, and unappealing taste. As a result, researchers at Texas A&M University, in collaboration with experts from the College of Engineering, the College of Pharmacy, and the School of Veterinary Medicine and Biomedical Sciences, have embarked on an innovative project to revolutionize pediatric medication using 3D printing technology.

With a grant of approximately $3 million from the National Institutes of Health (NIH), the aim of the project is to replace mass-produced tablets with standardized dosages and sizes, with a more flexible system that caters to the individual needs of children. Led by Mathew Kuttolamadom, associate professor at the Department of Engineering Technology and Industrial Distribution, the team intends to develop a manufacturing method that can adapt the dosage and size of medication according to the evolving requirements of pediatric patients from infancy to 17 years of age. This initiative is particularly significant in fields like pediatric oncology, where individualized treatment is crucial.

One of the main challenges in pediatric medication administration is the need for tailored, age-appropriate dosage forms, which has been well-documented by global initiatives like the World Health Organization’s “Make Medicines Child Size” campaign. Despite these efforts, preventable medication errors in pediatric patients, which often occur in critical settings like emergency rooms and neonatology units, continue to be a concern. Mistakes with medications can lead to severe harm or even death, highlighting the need for more accurate dosing and medication administration practices.

The potential of customized, 3D printed drugs to improve dosing and medication administration accuracy offers a game-changing solution to these challenges. By utilizing 3D printing techniques, the researchers aim to create medication tablets with tailored sizes, dosages, and even combinations of multiple medicines within a single tablet. This level of customization has never been achieved before and could significantly enhance the efficacy and safety of pediatric medication.

However, adapting 3D printing techniques to pharmaceuticals presents its own unique set of challenges. Kuttolamadom and his team are working to understand how these new drug-making methods function while ensuring the medicine remains effective throughout the process. Despite the challenges, Kuttolamadom has extensive experience in the field of 3D printing for pharmacological applications, having conducted research on personalized dose and controlled drug release medicines called printlets manufactured through selective laser sintering (SLS). His previous studies have highlighted the advantages of 3D printing in pharmaceuticals, such as its solvent-free nature and minimal post-processing requirements.

While Kuttolamadom’s project is groundbreaking, it is not the only one exploring the potential of 3D printing in pediatric medication customization. Researchers at University College London’s School of Pharmacy and the University of Michigan College of Pharmacy are also investigating ways to optimize 3D printed tablets for better drug release and easier ingestion by children.

The use of 3D printing in pediatric medication has already shown promise, with the Food and Drug Administration (FDA) approving the first 3D printed drug in 2015. With the expertise and dedication of researchers like Kuttolamadom and his team, the future of pediatric medication administration looks promising. By harnessing the power of 3D printing, the aim is to create a flexible and adaptive manufacturing system that ensures the safe and effective administration of medication to young patients, ultimately improving their health outcomes and quality of life.

The world of medicine is constantly evolving, with new technologies and innovations emerging all the time. One such innovation that has the potential to revolutionize healthcare is 3D printing. While 3D printing is not a new concept, its application in the medical field is still relatively new and holds great promise.

One area where 3D printing could particularly make a difference is in the creation of “polypills.” These pills combine multiple medications into a single tablet, making it easier for patients to take their medication as prescribed. This is especially beneficial for individuals who have to take multiple medications for various health conditions.

Traditionally, each medication would be manufactured separately and then packaged into individual bottles. This not only increases the risk of medication errors, but it also makes it more difficult for patients to keep track of which medications they need to take and when. However, with 3D printing, it becomes possible to create a single tablet that contains all the necessary medications in the correct dosages.

But the potential of 3D printing goes beyond just convenience and ease of use. In the future, this technology could be used to create personalized treatments for younger patients. Every patient is unique, and their bodies may respond differently to different medications. With 3D printing, it becomes possible to customize medication to suit the specific needs of each patient, ensuring better treatment outcomes.

Imagine a scenario where a child is diagnosed with a rare genetic disorder. Currently, treatment options may be limited, and medications may need to be administered in a trial and error manner. However, with 3D printing, doctors could create personalized medications based on the child’s genetic makeup and specific condition. This opens up a whole new realm of possibilities for tailored, precise treatments.

Of course, like any new technology, there are still challenges to overcome. The cost of 3D printing equipment and materials is currently high, making it inaccessible for many healthcare facilities. Additionally, regulations and standards need to be developed to ensure the safety and efficacy of 3D-printed medications.

However, as the field of 3D printing in medicine continues to evolve, these challenges are likely to be addressed. The potential benefits are too significant to ignore. As a healthcare professional, it is essential to stay up-to-date on the latest developments in 3D printing and its applications in the industry.

By staying informed, healthcare professionals can not only provide the best care for their patients but also explore opportunities to collaborate with third-party vendors and contribute to the advancement of this exciting technology. The world of medicine is on the cusp of a transformation, and 3D printing could be the building block for a future where treatments are more personalized and effective.

Original source

Share this story

Leave a Reply

Your email address will not be published. Required fields are marked *